Windtree Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Windtree Therapeutics

09/08/2023 13:01

* Windtree Therapeutics Inc  WINT.OQ  reported a quarterly
adjusted loss of $1.64​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 68 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Windtree Therapeutics Inc's reported EPS for the quarter
was a
loss of $1.64​.
    * The mean earnings estimate of analysts had fallen by
about 23.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Windtree Therapeutics Inc shares had risen by 12.8% this
quarter and lost 83.4% so far this year.
    * The company reported a quarterly loss of $6.6 million.
    * Wall Street's median 12-month price target for Windtree
Therapeutics Inc is $5.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 12:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.68          -1.64          Missed
 Mar. 31 2023      -0.56          -4.76          Missed
 Sep. 30 2022      -13.00         -6.50          Beat